RECORDATI
Disappointing earnings, trade tensions send European shares southThe STOXX 600 fell 0.1 per centas earnings streamed in with several big disappointments causing shares to slide.
AstraZeneca sells ageing beta-blocker to Recordati for $300 mlnAstraZeneca, which retains rights to the beta-blocker outside Europe, will continue to manufacture and ship product to Recordati under a su...
- Load More